propyl gallate has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, DC; Feng, C; Le, XF; Luo, HW; Luo, KQ; Tian, HL; Xu, NN; Yu, T; Zhou, LY | 1 |
| Jo, EJ; Kim, BC; Park, SJ | 1 |
2 other study(ies) available for propyl gallate and cytochrome c-t
| Article | Year |
|---|---|
A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Proliferation; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Doxorubicin; Female; HeLa Cells; Hep G2 Cells; HL-60 Cells; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasms; Paclitaxel; Phenanthrenes; Propyl Gallate; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptor, ErbB-2; Solubility; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Cytochromes c; Down-Regulation; Drug Synergism; Heme Oxygenase-1; Humans; Lung Neoplasms; Mitochondria; Propyl Gallate; Proteasome Endopeptidase Complex; Proteolysis; Proto-Oncogene Proteins c-bcl-2; Receptors, Cell Surface; Ubiquitin | 2016 |